{"id":"W3195489010","doi":"10.1055/s-0041-1723292","title":"CheckMate 77 T: A phase 3 trial of neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) followed by adjuvant NIVO in resectable early-stage non-small cell lung cancer (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Pneumologie","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Nivolumab; Oncology; Internal medicine; Adjuvant; Stage (stratigraphy); Chemotherapy; Lung cancer; Randomized controlled trial; Neoadjuvant therapy; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008259046,0.0007807997,0.0007043727,0.0002558905,0.000296429,0.0009409774,0.0008017218,0.001058828,0.008707605],"category_scores_gemma":[0.001016437,0.0001989756,0.001192468,0.0002216504,0.0005770441,0.0005457076,0.0003655097,0.002104564,0.001058064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001276199,"about_ca_system_score_gemma":0.001584852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002593228,"about_ca_topic_score_gemma":0.00815449,"domain_scores_codex":[0.999824,0.00008019534,0.000006846663,0.00002947783,0.00002284148,0.00003663233],"domain_scores_gemma":[0.9996269,0.00007476191,0.00008917757,0.00002582887,0.0000250262,0.0001584058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6468092,0.02191641,0.005317686,0.004776324,0.002175981,0.0003101085,0.0002964209,0.0041695,0.04204398,0.002027408,0.04673783,0.2234192],"study_design_scores_gemma":[0.7856354,0.1772373,0.01142596,0.0003580982,0.0009136925,0.0003182214,0.00008770474,0.00250902,0.003879834,0.0005602014,0.01701612,0.0000585169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9595824,0.009240396,0.001020831,0.002034077,0.0007860533,0.005512081,0.005443389,0.0005489889,0.01583168],"genre_scores_gemma":[0.95362,0.005419822,0.002976788,0.006820012,0.0003871538,0.006049285,0.009276229,0.0001191388,0.01533153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008707605,"threshold_uncertainty_score":0.02912986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02237433074829408,"score_gpt":0.3181726230854495,"score_spread":0.2957982923371554,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}